The Endocrine Heart: Natriuretic Peptides and Oxygen Metabolism in Cardiac Diseases

dc.contributor.authorArjamaa Olli
dc.contributor.organizationfi=biodiversiteettiyksikkö|en=Biodiversity unit|
dc.contributor.organizationfi=biologian laitos|en=Department of Biology|
dc.contributor.organization-code1.2.246.10.2458963.20.77193996913
dc.converis.publication-id68158125
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/68158125
dc.date.accessioned2022-10-27T11:45:10Z
dc.date.available2022-10-27T11:45:10Z
dc.description.abstractCirculating natriuretic peptides are widely used as tools in the diagnosis and follow-up of cardiac diseases, and their use has been increasing throughout other medical branches. After 40 years and more than 40,000 publications, their function in healthy human adults of reproductive age appears to remain confusing-with every physiology and pharmacology textbook telling a different story. In cardiology, mechanical load upon the heart is generally regarded as the condition that regulates the synthesis and release of natriuretic peptides. The key issue in cardiology remains how mechanical activity and oxygen consumption are related, and yet no published paper has shown that mechanical load does not increase oxygen consumption, as wall tension is a major determinant of myocardial oxygen consumption. However, this relationship has been largely neglected in studies on natriuretic peptides. Based on published papers, an outline is presented of how oxygen metabolism, related to mechanical stress, could play an important role in the pathophysiology of natriuretic peptides. The natriuretic peptide system might enhance oxygen transport by causing diuresis, natriuresis, and water transfer from the intra- to extravascular space, resulting in volume contraction and hemoconcentration, thus indirectly promoting the transfer of oxygen into tissues and organs. Mechanical stress and oxygen consumption are 2 sides of the same coin. The relationship between mechanical stress and oxygen metabolism, in the particular case of natriuretic peptides, represents a new avenue for clinical studies and will better explain the results of studies that have been published previously.
dc.format.pagerange1149
dc.format.pagerange1152
dc.identifier.eissn2589-790X
dc.identifier.jour-issn2589-790X
dc.identifier.olddbid171896
dc.identifier.oldhandle10024/154990
dc.identifier.urihttps://www.utupub.fi/handle/11111/29535
dc.identifier.urnURN:NBN:fi-fe2022012710534
dc.language.isoen
dc.okm.affiliatedauthorArjamaa, Olli
dc.okm.affiliatedauthorDataimport, Turun yliopiston ympäristöntutkimuskeskus
dc.okm.discipline3111 Biomedicineen_GB
dc.okm.discipline3121 Internal medicineen_GB
dc.okm.discipline3111 Biolääketieteetfi_FI
dc.okm.discipline3121 Sisätauditfi_FI
dc.okm.internationalcopublicationnot an international co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA2 Scientific Article
dc.publisherElsevier Inc.
dc.publisher.countryUnited Statesen_GB
dc.publisher.countryYhdysvallat (USA)fi_FI
dc.publisher.country-codeUS
dc.relation.doi10.1016/j.cjco.2021.04.005
dc.relation.ispartofjournalCJC Open
dc.relation.issue9
dc.relation.volume3
dc.source.identifierhttps://www.utupub.fi/handle/10024/154990
dc.titleThe Endocrine Heart: Natriuretic Peptides and Oxygen Metabolism in Cardiac Diseases
dc.year.issued2021

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
1-s2.0-S2589790X2100113X-main.pdf
Size:
361.82 KB
Format:
Adobe Portable Document Format
Description:
Publisher's PDF